Showing results (161-170 of 179) with videos related to
Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2023
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancerH Borghaei, F de Marinis, D Dumoulin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2020
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trialS Popat, A Curioni-Fontecedro, U Dafni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 15, 2025
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trialE Felip, S Popat, U Dafni, et al.Annals of Human Genetics|August 14, 2002
Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac diseaseS Popat, N Hearle, L Hogberg, et al.Cancer Research|June 18, 2015
Pharmacological Ascorbate Radiosensitizes Pancreatic CancerJuan Du, John A Cieslak, Jessemae L Welsh, et al.Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
NgR1 binding to reovirus reveals an unusual bivalent interaction and a new viral attachment proteinDanica M Sutherland, Michael Strebl, Melanie Koehler, et al.JAMA Oncology|October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical TrialKartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.Journal of Medical Genetics|October 3, 1999
Contribution of the MHC region to the familial risk of coeliac diseaseS Bevan, S Popat, C P Braegger, et al.Nature Communications|December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphomaJulia Paczkowska, Ming Tang, Kyle T Wright, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2021
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trialS Peters, J-L Pujol, U Dafni, et al.Pageof 18